Sleep is My Waking Passion
Hosted by Dr. Alison Kole—a triple-boarded pulmonary critical care and sleep medicine physician, reformed chronic insomniac, devoted mom, and unapologetic sleep health creator—this hit podcast takes you on the real, unfiltered journey inside the science and soul of sleep. Each week, with wisdom forged from the trenches of night shifts and the chaos of motherhood, Alison sits down with top-tier experts and ordinary people with extraordinary sleep stories, unraveling how sleep shapes happiness, health, and destiny. If you want the 360° truth—the wins, the setbacks, the breakthroughs—about why every hour of sleep could be the most important hour of your life, this is the show that will change how you see your pillow forever. Sleep isn’t just her passion—it’s the key to waking up to your potential. Hit subscribe and transform your nights, days, and dreams.
Sleep is My Waking Passion
Can Weight Loss Drugs Cure Sleep Apnea? Dr. Ruchir Patel Breaks It Down"
Dr. Ruchir Patel is a trailblazing sleep medicine expert, entrepreneur, and industry consultant with over 15 years of experience in the field. As the founder of multiple innovative healthcare ventures, including Knightly, Attara Labs, and the Insomnia and Sleep Institute of Arizona, Dr. Patel is redefining how sleep disorders are diagnosed and treated. With expertise spanning neuromodulation, transcranial magnetic stimulation (TMS), and obesity medicine, he is passionately committed to improving patient outcomes through evidence-based care and cutting-edge research.
In this episode of Sleep Is My Waking Passion, host Dr. Alison Kole dives deep with Dr. Patel into the intersection of weight loss drugs like tirzepatide (Monjaro/ZepBound) and their potential role in treating obstructive sleep apnea (OSA). From the science behind GLP-1 agonists to the challenges of navigating insurance hurdles, Dr. Patel shares his candid insights on prescribing practices, patient counseling, and the broader implications for sleep medicine. Together, they explore critical topics such as metabolic inflammation, collaborative care models between specialties, and why tirzepatide should be seen as a powerful tool—not a standalone solution—for OSA management.
